A PYMNTS Company

US: Walgreens in talks to buy AmerisourceBergen: WSJ

By  |  February 13, 2018

The largest US drugstore operator Walgreens Boots Alliance  has made a takeover approach to drug distributor AmerisourceBergen the Wall Street Journal reported on Monday, outlining a deal that would accelerate healthcare sector consolidation.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Walgreens is valued at $67.82 billion and AmerisourceBergen has a market capitalization of US$19.65 billion, according to WSJ.

    Healthcare payers and pharmacies are responding to a shifting landscape, including changes in the US Affordable Care Act, rising drug prices and the threat of competition from online retailers such as Amazon.com.

    A new deal by Walgreens would follow the US$69 billion acquisition of health insurer Aetna Inc by drugstore rival CVS Health Corp and would also reflect a move toward vertical consolidation, where members of a supply chain combine.

    Full Content: The Wall Street Journal

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.